Avastin may help slow ovarian cancer tumors

Read?more: Local, State, National, International, Health, Community, News, Avastin, FDA, The New England Journal of Medicine, Ovarian Cancer, Chemotherapy Cancer, Ovarian Chemo, Tumor Growth Ovarian Cancer, Food and Drug Administration, Slow Ovarian Tumor Growth, Avastin Side Effects

Studies show Avastin may help some with ovarian cancer, but doesn't extend life expectancy.

New studies suggest that the drug?Avastin, when treating women with ovarian cancer, can slow tumor growth when added to chemotherapy.

But- it's not clear whether the drug may improve life expectancy.
The news comes less than a week after officials in Europe approved Avastin for treating advanced ovarian cancer.

It has not yet been approved by the?Food and Drug Administration?to treat ovarian cancer in the U-S.

"I have no doubt that Avastin is a very powerful drug for some patients," said Dr. Gabriel Hortobagyi, chair of MD Anderson Cancer Center department of breast medical oncology, according?The Los Angeles Times. "The problem with Avastin is we don?t have a biomarker to help us identify the sub-group."

Results of the studies are in?the New England Journal of Medicine.

Last month, the F-D-A withdrew approval of Avastin for breast cancer because it did not extend life and can have serious side effects.

(CNN contributed to this article)

Source: http://www.northwestohio.com/news/story.aspx?id=702389

golden globe nominees megyn kelly unclaimed money richard hamilton richard hamilton paris jackson paris jackson